Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2003
06/05/2003US20030103958 Gene expression; for catalysis of phytate to inositol and inorganic phosphate; heat resistance; for production of animal feeds
06/05/2003US20030103957 Comprises adenosine-diphosphate transferase activity; drug delivery; for suppressing inhibition of neuronal axon growth
06/05/2003US20030103956 Use of HIF-1a variants to accelerate wound healing
06/05/2003US20030103955 For topical application; high penetration through skin; antiinflammatory agents
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103945 Methods and compositions for stimulating axon regeneration and preventing neuronal cell degeneration
06/05/2003US20030103943 Multiple site delivery of adenoviral vector for the induction of angiogenesis
06/05/2003US20030103941 Administering an interluekin-10 expressing nucleic acid to wound site to promote expression of exogenous interleukin-10 polypeptide
06/05/2003US20030103938 Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003US20030103936 Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides
06/05/2003US20030103931 Crosslinked polylysine
06/05/2003US20030103917 Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres
06/05/2003US20030101995 Dry powder inhalation system for transpulmonary administration
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2471833A1 Methods of compositions for normalizing lipid levels in mammalian tissues
06/05/2003CA2468832A1 Method for producing a recombinant polypeptide
06/05/2003CA2468718A1 Fusion proteins containing tlp peptides
06/05/2003CA2468582A1 Materials and methods for making improved micelle compositions
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468501A1 T-cell epitodes in carboxypeptidase g2
06/05/2003CA2468499A1 Erythropoietin dosing regimen for treating anemia
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468344A1 Methods and compositions for treating lesions of the respiratory epithelium
06/05/2003CA2468326A1 Protein-protein interactions in human immunodeficiency virus
06/05/2003CA2468250A1 Pharmaceutical composition for nasal absorption
06/05/2003CA2468246A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003CA2468240A1 Muscle transcription factors
06/05/2003CA2468230A1 Glycopeptide remodeling using amidases
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2468154A1 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467645A1 Composition for removing fibrin-bound blood clots from a catheter
06/05/2003CA2467114A1 A food grade lantibiotic from streptococcus macedonicus and uses thereof
06/05/2003CA2466931A1 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466841A1 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid .beta., prion protein, amylin, .alpha.-synuclein, or polyglutamine repeats for induction of an immune response thereto
06/05/2003CA2466478A1 Gene therapy agents for neurodegenerative diseases
06/05/2003CA2465072A1 Treatment of micro-organism infection
06/05/2003CA2435758A1 Polynucleotide therapy_against autoantigens for treating insulin dependent diabetes mellitus
06/05/2003CA2413315A1 Antithrombin for the prevention and therapy of vasculoproliferative disorders
06/04/2003EP1316611A1 L-methionine gamma-lyase with modified function
06/04/2003EP1316604A1 Novel thymidylate synthase mutants
06/04/2003EP1316562A2 Composition comprising a covalent polyethylene glycol (PEG)-protein adduct
06/04/2003EP1316561A1 Fusion protein having enhanced in vivo erythropoietin activity
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1316319A1 A novel gene therapy agent for haemophilia b and its preparation method
06/04/2003EP1316315A1 Medicinal compositions
06/04/2003EP1316313A2 Composition for the treatment of ischemic stroke containing zonampanel and a tissue plasminogen activator
06/04/2003EP1315970A1 Nucleic acid sequences and proteins involved in cellular senescence
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315963A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315822A2 Modified construct downstream of the initiation codon for recombinant protein overexpression
06/04/2003EP1315817A2 18431 and 32374, human protein kinase family members and uses therefor
06/04/2003EP1315814A2 Adhesion molecules
06/04/2003EP1315813A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315809A2 Control of crop pests and animal parasites through direct neuronal uptake
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315760A2 Endoglin-specific polypeptide, production and use thereof
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315756A2 Electroprocessed fibrin-based matrices and tissues
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315754A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/04/2003EP1315752A1 Modified proteins, isolated novel peptides, and uses thereof
06/04/2003EP1315750A2 Cyclic peptides having melanocortin-4 receptor agonist activity
06/04/2003EP1315749A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport
06/04/2003EP1315747A2 Maurotoxin, pi1 and hstx1 derivatives
06/04/2003EP1315746A1 Codon optimised recombinant dermaphagoides allergens
06/04/2003EP1315743A2 Mammalian genes; related reagents and methods
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315739A2 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
06/04/2003EP1315738A1 Extended native chemical ligation
06/04/2003EP1315695A2 Benzene tricarboxylic acid amides as insulin receptor activators
06/04/2003EP1315539A2 Antithrombotic compositions
06/04/2003EP1315523A1 Vp22 protein / nucleic acid aggregates, uses thereof
06/04/2003EP1315519A2 Pharmaceutical compositions and methods useful for modulating angiogenesis
06/04/2003EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
06/04/2003EP1315516A2 Modulation of beta-amyloid levels by beta-secretase bace2
06/04/2003EP1315515A2 Method for treating schizophrenia and related psychoses, and the use of erythropoietin or erythropoietin derivatives for treating schizophrenic disorders and related psychoses
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315510A2 Methods and compositions for the repair and/or regeneration of damaged myocardium
06/04/2003EP1315507A2 Hpv-specific short-mers
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315487A2 Flavoring systems for pharmaceutical compositions and methods of making such compositions
06/04/2003EP1315484A1 Taxane-based compositions and methods of use
06/04/2003EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour
06/04/2003EP1214347B1 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
06/04/2003EP1196444B1 Extendin-4 conjugates and their medical use
06/04/2003EP1162995B1 Enzymes for the treatment of diabetes mellitus type i
06/04/2003EP1143997B1 Tumor necrosis factor antagonists and their use in endometriosis treatment
06/04/2003EP1135177B1 Porous composite matrix and the production and use thereof
06/04/2003EP1107751B1 Medicament containing platinum complex compounds and the use thereof
1 ... 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 ... 3163